» Articles » PMID: 17099708

Bace1 Modulates Myelination in the Central and Peripheral Nervous System

Overview
Journal Nat Neurosci
Date 2006 Nov 14
PMID 17099708
Citations 312
Authors
Affiliations
Soon will be listed here.
Abstract

Bace1 is an endopeptidase that cleaves the amyloid precursor protein at the beta-secretase site. Apart from this cleavage, the functional importance of Bace1 in other physiological events is unknown. We show here that Bace1 regulates the process of myelination and myelin sheath thickness in the central and peripheral nerves. In Bace1-null mice, the process of myelination was delayed and myelin thickness was markedly reduced, indicating that genetic deletion of Bace1 causes hypomyelination. Bace1-null mice also showed altered neurological behaviors such as elevated pain sensitivity and reduced grip strength. Further mechanistic studies showed an altered neuregulin-Akt signaling pathway in Bace1-null mice. Full-length neuregulin-1 was increased and its cleavage product was decreased in the CNS of Bace1-null mice. Furthermore, phosphorylated Akt was also reduced. Based upon these and previous studies, we postulate that neuronally enriched Bace1 cleaves neuregulin-1 and that processed neuregulin-1 regulates myelination by means of phosphorylation of Akt in myelin-forming cells.

Citing Articles

Drug delivery strategies with lipid-based nanoparticles for Alzheimer's disease treatment.

Jang Y, Kang S, Park H, Lee D, Kim J, Kim J J Nanobiotechnology. 2025; 23(1):99.

PMID: 39930497 PMC: 11809104. DOI: 10.1186/s12951-025-03109-3.


Adaptation in the Alleyways: Candidate Genes Under Potential Selection in Urban Coyotes.

Kreling S, Vance S, Carlen E Genome Biol Evol. 2025; 17(1).

PMID: 39786569 PMC: 11775663. DOI: 10.1093/gbe/evae279.


Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer's disease.

Ishii A, Pathoulas J, MoustafaFathy Omar O, Ge Y, Yao A, Pantalena T Mol Neurodegener. 2024; 19(1):83.

PMID: 39548583 PMC: 11568619. DOI: 10.1186/s13024-024-00759-z.


Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease.

Zota I, Chanoumidou K, Gravanis A, Charalampopoulos I Front Cell Neurosci. 2024; 18:1422130.

PMID: 39285941 PMC: 11402763. DOI: 10.3389/fncel.2024.1422130.


Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer's disease.

Rajani R, Ellingford R, Hellmuth M, Harris S, Taso O, Graykowski D PLoS Biol. 2024; 22(7):e3002727.

PMID: 39042667 PMC: 11265669. DOI: 10.1371/journal.pbio.3002727.